Suppr超能文献

Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents.

作者信息

Montironi R, Mazzucchelli R, Marshall J R, Bartels P H

机构信息

Institute of Pathological Anatomy and Histopathology, University of Ancona, Ospedale Regionale, Italy.

出版信息

J Clin Pathol. 1999 Nov;52(11):793-803. doi: 10.1136/jcp.52.11.793.

Abstract
摘要

相似文献

2
Chemoprevention of prostate cancer.
Semin Urol. 1995 May;13(2):122-9.
3
Chemoprevention for prostatic intraepithelial neoplasia.
Eur Urol. 1996;30(2):269-78. doi: 10.1159/000474180.
4
Prostatic intraepithelial neoplasia and prostate cancer.
Panminerva Med. 2002 Sep;44(3):213-20.
5
The future of prostate cancer prevention.
Ann N Y Acad Sci. 2001 Dec;952:145-52. doi: 10.1111/j.1749-6632.2001.tb02735.x.
10
Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.
Prostate Cancer Prostatic Dis. 2007;10(4):378-83. doi: 10.1038/sj.pcan.4500971. Epub 2007 Apr 24.

引用本文的文献

2
EPMA position paper in cancer: current overview and future perspectives.
EPMA J. 2015 Apr 15;6(1):9. doi: 10.1186/s13167-015-0030-6. eCollection 2015.
3
[A critical assessment of phytotherapy for prostate cancer].
Urologe A. 2009 Mar;48(3):270-1, 274-83. doi: 10.1007/s00120-008-1929-5.
4
The potential for prostate cancer chemoprevention.
Rev Urol. 2002;4 Suppl 5(Suppl 5):S11-7.
5
Tissue-based assay for ornithine decarboxylase to identify patients likely to respond to difluoromethylornithine.
J Histochem Cytochem. 2004 Nov;52(11):1467-74. doi: 10.1369/jhc.4A6358.2004.
6
Immunopathological prognostic and predictive factors in prostate cancer.
Int Urol Nephrol. 2002;34(1):63-71. doi: 10.1023/a:1021306928664.
7
Prognostic factors in prostate cancer.
BMJ. 2001 Feb 17;322(7283):378-9. doi: 10.1136/bmj.322.7283.378.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验